FdaApplication
NDA 020236
Identifiers
- fda_app_no: NDA020236
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1994-02-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SEREVENT | SALMETEROL XINAFOATE | EQ 0.021MG BASE/INH | AEROSOL, METERED;INHALATION |
1 product